Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Samuel P Dickson, Benjamin A Haaland, Kent Hendrix, et al.
Muscle & Nerve
|
May 4, 2022
Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes
Sabrina Paganoni, Claire Watkins, Matthew Cawson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Garrett B Duncan, Tyler M Duke, Samuel B Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Joseph Geraci, Patrick P O'Keefe, Bessi Qorri, et al.
Biomarkers in Medicine
|
May 26, 2021
Perspectives on statistical strategies for the regulatory biomarker qualification process
Suzanne B Hendrix, Robin Mogg, Sue Jane Wang, et al.
Neurology and Therapy
|
September 17, 2024
Development of a General Composite Scale (GENCOMS) for Progressive Neurodegenerative Diseases and Implications for the Assessment of Disease-Modifying Therapies
Samuel P Dickson, Craig H Mallinckrodt, Basia Rogula, et al.
American Journal of Human Genetics
|
April 5, 2011
A genome-wide comparison of the functional properties of rare and common genetic variants in humans
Qianqian Zhu, Dongliang Ge, Jessica M Maia, et al.
Journal of Alzheimer'S Disease : JAD
|
September 15, 2025
Efficacy of AD04, an aluminum-based vaccine adjuvant, in patients with early Alzheimer's disease: Post hoc analysis of AFF006 (NCT01117818), a proof-of-concept, phase 2 randomized controlled trial
Benjamin Haaland, Samuel P Dickson, Agustin Fernández Santana, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 27, 2025
Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer's disease
Garrett B Duncan, Samuel P Dickson, Johanne M Kaplan, et al.
Plos One
|
March 4, 2014
Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation
Karen A O Martins, Jesse T Steffens, Sean A van Tongeren, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Samuel P Dickson, Benjamin A Haaland, Kent Hendrix, et al.
Muscle & Nerve
|
May 4, 2022
Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes
Sabrina Paganoni, Claire Watkins, Matthew Cawson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Garrett B Duncan, Tyler M Duke, Samuel B Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Joseph Geraci, Patrick P O'Keefe, Bessi Qorri, et al.
Biomarkers in Medicine
|
May 26, 2021
Perspectives on statistical strategies for the regulatory biomarker qualification process
Suzanne B Hendrix, Robin Mogg, Sue Jane Wang, et al.
Neurology and Therapy
|
September 17, 2024
Development of a General Composite Scale (GENCOMS) for Progressive Neurodegenerative Diseases and Implications for the Assessment of Disease-Modifying Therapies
Samuel P Dickson, Craig H Mallinckrodt, Basia Rogula, et al.
American Journal of Human Genetics
|
April 5, 2011
A genome-wide comparison of the functional properties of rare and common genetic variants in humans
Qianqian Zhu, Dongliang Ge, Jessica M Maia, et al.
Journal of Alzheimer'S Disease : JAD
|
September 15, 2025
Efficacy of AD04, an aluminum-based vaccine adjuvant, in patients with early Alzheimer's disease: Post hoc analysis of AFF006 (NCT01117818), a proof-of-concept, phase 2 randomized controlled trial
Benjamin Haaland, Samuel P Dickson, Agustin Fernández Santana, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 27, 2025
Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer's disease
Garrett B Duncan, Samuel P Dickson, Johanne M Kaplan, et al.
Plos One
|
March 4, 2014
Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation
Karen A O Martins, Jesse T Steffens, Sean A van Tongeren, et al.
Page
of 4